资讯
Emily Standley Allard on MSN
Psychedelic Therapy: From Taboo to Mainstream Healthcare
Once relegated to the fringes of society and labeled as countercultural, psychedelics are now experiencing a renaissance—this time within the walls of mainstream healthcare. Psychedelic therapy, ...
Tutorial simple copper wire bracelet - designer handmade jewelry Welcome to the online classes at home with the theme diy ...
According to the study, a single, medically supervised dose of lysergic acid diethylamide — better known as LSD — can provide ...
A single dose of LSD provided lasting relief for patients in a groundbreaking study published in the Journal of the American ...
Research finds that a single dose of LSD can alleviate the symptoms of anxiety in those who do not find relief from other ...
An early trial with about 200 people tested the effects of LSD on generalized anxiety disorder and found promising results.
A study of a pharmaceutical form of the psychedelic drug lysergic acid diethylamide suggests it might relieve anxiety ...
About half of people with generalised anxiety disorder don’t respond to common treatments with antidepressants – but ...
A groundbreaking Genomic Press interview with Professor Gregor Hasler explores revolutionary psychedelic research reshaping ...
The Studio LSD IPO witnessed a fairly strong response from investors, closing with an overall subscription of 3.23 times. The issue received 4.21 crore bids against 1.30 crore shares on offer.
Scientists are exploring a new class of origami structures that could help design and build different shapes for use in space. These structures are expected to be even more compact and reliable.
Studio LSD IPO allotment: The allotment status for Studio LSD's SME IPO is expected to be finalised today. Investors who subscribed to the issue can check their allotment details through the registrar ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果